参考文献/References:
[1] Jamba A,Kondo S,Urushihara M,et al.Hydrogen peroxide-inducible Clone-5 regulates mesangial cell proliferation in proliferative glomerulonephritis in mice[J].PloS one,2015,10(4):1415-1417.
[2] Ding K,Wang Y,Jiang W,et al.Qian Yang Yu Yin Granule-containing serum inhibits angiotensin II-induced proliferation,reactive oxygen species production,and inflammation in human mesangial cells via an NADpH oxidase 4-dependent pathway[J].BMC Complementary and Alternative Medicine,2015,15(1):81.
[3] Kitching AR,Holdsworth SR.The emergence of TH17cells as effectors of renal injury[J].Journal of the American Society of Nephrology,2011,22(2):235-238.
[4] Letian Z,Fuyou L.Th17细胞与肾小球疾病的研究进展[J].中南大学学报:医学版, 2013,38(4):432-436.
[5] Huenemoerder S,Holzer J,Paust HJ,et al.Characterization of the renal CD4+T-cell response in experimental autoimmune glomerulonephritis[J].Immunology,2012,137:384-385.
[6] 薛 茹,王 墨,李 秋.槐耳清膏对IL-17诱导的系膜细胞增殖和分泌纤连蛋白的影响\[C\]//中华医学会第十七次全国儿科学术大会文集.中华医学会儿科专业委员会,郑州,2012:12-13.
[7] Hu Z,Qiu L,Xiao Z,et al.Effects of esculentoside A on autoimmune syndrome induced by Campylobacterjejuni in mice and its modulation on T-lymphocyte proliferation and apoptosis[J].International immunopharmacology,2010,10(1):65-71.
[8] Liu C,Dong L,Sun Z,et al.Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway[J].Phytother Res,2018,6:123-124.
[9] Zhong W,Jiang L,Wei J,et al.Protective effect of esculentoside A on lipopolysaccharide-induced acute lung injury in mice[J].Journal of Surgical Research,2013,185(1):364-372.
[10] 马华林,张欣洲,张祥贵.商陆皂苷甲治疗BXSB狼疮性肾炎小鼠的实验研究[J].广东医学,2011,32(12):1540-1542.
[11] Ma HL,Zhang XG,Zhang XZ,et al.The effect of esculentoside A on lupus nephritis-prone BXSB mice[J].Arch Med Sci,2013,9(2):354-360.
[12] 张祥贵.商陆皂苷甲对BXSB小鼠肾脏细胞凋亡及Bax和Bcl-2表达的影响[J].广东医学,2013,32(21):2775-2778.
[13] 汤杰印,孟令国,张祥贵.商陆皂苷甲对BXSB小鼠肾组织pCNA、Caspase-3、Fas和FasL表达影响[J].实用中医内科杂志,2014,28(5):76-80.
[14] 张祥贵,汤杰印.商陆皂苷甲对肾小球系膜细胞增殖的影响[J].陕西中医,2013,34(8):1075-1077.
[15] 张祥贵,汤杰印.商陆皂苷甲对IL-1β诱导的肾小球系膜细胞增殖及CDK2、p27的影响[J].重庆医学,2013,42(21):2496-2499.
[16] 徐丽君,汤杰印,张祥贵,等.商陆皂苷甲对白细胞介素1β诱导的肾小球系膜细胞增殖及Caspase-3的影响[J].当代医学,2013,19(35):5-7.
[17] 汤杰印,董 扬,张祥贵,等.商陆皂苷甲对IL-1β诱导的肾小球系膜细胞ERK通路活化的影响[J].广东医学,2016,37(11):1613-1617.
[18] 汤杰印,董 扬,张祥贵,等.商陆皂苷甲对IL-1β诱导的肾小球系膜细ERK1/2-AP1通路活化的影响[J].重庆医学,2017,44(16):2183-2186.
[19] 薛 帆,刘百薇,范晶晶.IL-17与自身免疫性疾病关系的研究进展[J].中国当代医药,2010,17(20):16-17.
[20] Kwan T,Chadban SJ,Ma J,et al.IL-17 deficiency attenuates allograft Injury and prolongs survival in a murine model of fully MHC-Mismatched renal allograft transplantation[J].American Journal of Transplantation Rearsch,2015.
[21] Lu G,Zhang X,Shen L,et al.CCL20 secreted from Ig A1-stimulated human mesangial cells recruits inflammatory Th17 cells in Ig A nephropathy[J].PloS One,2017,12(5):e0178352.
[22] Matsumoto K,Kanmatsuse K.Interleukin-17 stimulates the release of pro-inflammatory cytokines by blood monocytes in patients with Ig A nephropathy[J].Scandinavian Journal of Urology and Nephrology,2003,37(2):164-171.
[23] 杨青梅.原发性Ig A肾病外周血IL-17及TGF-β1的表达及意义[J].中国临床医学,2013,20(2):154-156.
[24] 徐 靓,张慧涛,郑 晶,等.白细胞介素17在狼疮性肾炎小鼠中的表达及抗白细胞介素17抗体的干预作用[J].中国病理生理杂志,2014,30(2):343-346.
[25] Xiao ZY,Zheng QY,Jiang YY,et al.Effects of esculentoside A on production of interleukin-1,2,and prostaglandin E2[J].Acta Pharmacologica Sinica,2004,25(6):817-821.
[26] 周 倩,姚广涛,金若敏.商陆皂苷甲的肾细胞毒性作用[J].中国药理学与毒理学杂志,2013,28(3):114.
[27] 王 莉.Th17/Treg 细胞失衡在儿童原发性肾病综合征发病中的分子机制研究[D].重庆:重庆医科大学,2010.
[28] Yang S,Wang Y,Mei K,et al.Tumor necrosis Factor Receptor 2(TNFR2).Interleukin-17 receptor D(IL-17RD) heteromerization reveals a novel mechanism for NF-KB activation[J].Journal of Biological Chemistry,2015,290(2):861-871.
[29] Roussel L,Houle F,Chan C,et al.IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation[J].The Journal of Immunology,2010,184(8):4531-4537.
[30] Meyer DM,Jesson MI,Li X,et al.Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor,CP-690,550,in rat adjuvant-induced arthritis[J].Journal of Inflammation,2010,7(1):41.